DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
批准号:
8146032
负责人:
MICHAEL T MCMAHON
金额:
$33.8万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-22 至 2014-08-31
关键词:
Acute Liver FailureAlginatesAmino AcidsAntibodiesApoptosisArginineAttentionBiocompatibleCell LineCell SurvivalCell TherapyCell physiologyCellsChemicalsClinicClinicalColorContrast MediaCrosslinkerDetectionDiabetic mouseDiscriminationDiseaseEncapsulatedEnvironmentFirefly LuciferasesGoalsHemophilia AHumanImageImageryIn VitroIndividualInsulinInsulin-Dependent Diabetes MellitusIslet CellIslets of LangerhansIslets of Langerhans TransplantationLabelLibrariesLifeLipidsLiposomesMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMeasuresMembraneMesenchymalMesenchymal Stem CellsMetalsMethodsMicroencapsulationsMonitorMusParkinson DiseasePatientsPeptidesPhysiologicalPopulationProductionReportingSignal TransductionSourceStagingStem cellsStreptozocinTechniquesTestingTherapeutic immunosuppressionTimeToxic effectTreatment ProtocolsValidationbasecapsulecell capsuledesignfunctional statusglycemic controlin vivoinsulin secretioninsulinomaisletmouse modelpre-clinicalpreclinical studypreventpublic health relevanceremote sensingsmall molecule librariessuccess
中文摘要
描述(由申请人提供):良好的血糖控制对于减少I型糖尿病(TIDM)的终末期并发症至关重要,因此,胰岛移植(ITx)近年来受到了相当大的关注,治疗中的并发症之一是寻找有效的方法来防止排斥反应。胰岛的免疫分离提供了一种减少或避免免疫抑制治疗的方法。在最常用的免疫分离方法微囊化中,单个胰岛被薄的海藻酸盐膜包围,该膜可渗透胰岛素和代谢物,但不能渗透天然抗体。然而,这些胰岛的生存能力,特别是胰岛素分泌对治疗的成功至关重要,并且对改进治疗方案至关重要。该建议的重点是生产微米大小的CEST MR可检测的海藻酸盐胶囊,其中包含胰岛和间充质干细胞,适用于治疗T1DM。这些胶囊将内置CEST MR造影剂,以允许:1)检测,2)区分被封装的胰岛细胞和间充质干细胞,3)遥感环境的pH值。CEST对比的来源将是6-24个氨基酸的长肽和嵌入藻酸盐中的CEST脂质体。我们将使用裸鼠糖尿病模型进行临床前研究,通过萤火虫荧光素酶的表达来监测被封装的胰岛/间充质细胞的状态。
英文摘要
DESCRIPTION (provided by applicant): Good glycemic control is critical in reducing the end-stage complications of Type I Diabetes Mellitus (TIDM) and, for this reason, islet transplantation (ITx) has received considerable attention in recent years, with one of the complications in the treatment involves finding an effective means to prevent rejection. Immuno-isolation of islets provides a means to reduce or avoid immunosuppressive therapy altogether. In the most commonly used method of immuno-isolation, microencapsulation, individual islets are surrounded with thin alginate membranes that are permeable to insulin and metabolites, but are impermeable to native antibodies. However, the viability and in particular the insulin secretion of these islets are critical for the success of the therapy, and would be important to monitor for refinement of the treatment protocol. This proposal is focused on the production of micron sized CEST MR detectable alginate capsules containing both islet and mesenchymal stem cells which are appropriate for the treatment of T1DM. These capsules will have CEST MR contrast agents built into the capsule to allow: 1) detection, 2) discrimination between encapsulated islet and mesynchymal stem cells and 3) remote sensing of the pH of the environment. The source of the CEST contrast will be 6-24 amino acid long peptides and CEST liposomes embedded within the alginate. We will perform pre-clinical studies using a nude based mouse model of diabetes to allow monitoring of the status of encapsulated islets/ mesenchymal cells through firefly luciferase expression.
PUBLIC HEALTH RELEVANCE: Islet transplantation (ITx) has received considerable attention in recent years for treatment of Type 1 Diabetes Melitus (T1DM). This proposal is focused on the production of immunoprotective islet cell capsules which are appropriate for treatment and allow MR monitoring of the pH these islets using biodegradable CEST contrast agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema
-
批准号:10551303
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2020
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema
-
批准号:10337274
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2020
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:10226212
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2017
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8479358
-
项目类别:
-
资助金额:$57.81万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8292578
-
项目类别:
-
资助金额:$61.89万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8677891
-
项目类别:
-
资助金额:$56.52万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8305994
-
项目类别:
-
资助金额:$60.96万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8023872
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8323997
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8525116
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
16.4T Vertical Wide Bore Animal MR Imager
-
批准号:7498705
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2009
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7448639
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7130476
-
项目类别:
-
资助金额:$11.59万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7265096
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7667850
-
项目类别:
-
资助金额:$12.82万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7912901
-
项目类别:
-
资助金额:$13.2万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
A SOLID STATE NMR INVESTIGATION OF BACTERIORHODOPSIN
-
批准号:6518893
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2001
-
负责人:MICHAEL T MCMAHON
-
依托单位:
A SOLID STATE NMR INVESTIGATION OF BACTERIORHODOPSIN
-
批准号:6294279
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2001
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:9984374
-
项目类别:
-
资助金额:$31.04万
-
财政年份:--
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:9358163
-
项目类别:
-
资助金额:$27.62万
-
财政年份:--
-
负责人:MICHAEL T MCMAHON
-
依托单位:
海外基金